Cormorant Asset Management’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Cormorant Asset Management’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,429,200	Closed	-$51.4M	–	126
2020 Q4	$51.4M	Sell	1,429,200 -155,800	-10%	-$5.46M	1.22%	30
2020 Q3	$44.5M	Buy	1,585,000 +72,500	+5%	+$2.57M	1.71%	21
2020 Q2	$65.5M	Sell	1,512,500 -250,000	-14%	-$11.3M	2.5%	12
2020 Q1	$67M	Buy	1,762,500 +265,000	+18%	+$10.3M	3.11%	8
2019 Q4	$40.7M	Buy	+1,497,500	New	+$37.7M	1.62%	21

Cormorant Asset Management's VIE Position: Q1 2021 in Review

Cormorant Asset Management sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 1,429,200 shares — an estimated $51.4M sold.

Cormorant Asset Management first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $67M in Q1 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Cormorant Asset Management reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Cormorant Asset Management sold 1,429,200 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $51.4M.
Cormorant Asset Management first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Cormorant Asset Management's Viela Bio, Inc. Common Stock position peaked at $67M in Q1 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Cormorant Asset Management's 13F filing for Q1 2021, filed 17 May 2021.